Oct 1 |
The Covid Era Tech Promises To Reinvent Cancer Treatment
|
Oct 1 |
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
|
Oct 1 |
Is Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip?
|
Oct 1 |
MRNA Begins Dosing in Pivotal Study on Norovirus Vaccine
|
Oct 1 |
Company News for Oct 1, 2024
|
Oct 1 |
IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply
|
Oct 1 |
Moderna doses first subject in Phase III trial of mRNA norovirus vaccine in US
|
Oct 1 |
Moderna, Cenra Healthcare enter JV to promote mRNA respiratory vaccine in Taiwan
|
Oct 1 |
Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines
|
Sep 30 |
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
|